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Background: The accuracy of endoscopic ultrasonography (EUS) for preoperative staging of gastric cancer varies.
The aim of this study was to investigate the accuracy of EUS tumor (T) and node (N) staging, and to identify the
histopathological factors influencing accuracy based on the detailed tumor depth of gastric cancer.
Methods: In total, 309 patients with gastric cancer with confirmed pathological staging underwent EUS
examination for preoperative staging at Seoul St. Mary’s Hospital, Korea, between January and December 2009.
The T and N staging of EUS and the pathologic report were compared.
Results: The overall accuracies of EUS for T stage and the detailed T stages were 70.2% and 43.0%, respectively. In
detailed stage, tumors greater than 50 mm in diameter were significantly associated with T overstaging (odds ratio
(OR) = 2.094). The overall accuracy of EUS for N staging was 71.2%. Tumor size (20 mm ≤ size < 50 mm, OR = 4.389;
and 50 mm ≤ size, OR = 8.170), cross-sectional tumor location (circumferential, OR = 4.381) and tumor depth
(submucosa, OR = 3.324; muscular propria, OR = 6.923; sub-serosa, OR = 4.517; and serosa-exposed, OR = 6.495) were
significant factors affecting incorrect nodal detection.
Conclusions: Careful attention is required during EUS examination of large-sized gastric cancers to increase accuracy,
especially for T staging.
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Gastric cancer is the second leading cause of cancer
deaths worldwide [1]. Removal of a primary tumor by
perigastric lymphadenectomy is accepted as the only way
to increase long-term survival in patients with gastric
cancer [2]; however, the operative method and access
route can vary, based on preoperative tumor stage and
tumor characteristics. Compared with serosal-exposed
lesions of with a tumor (T) stage of greater than T3,
which can be distinguished somewhat easily, distinguish-
ing preoperative tumor depths for gastric cancers less
than T2 is crucial because it determines the operative
method, including choice of endoscopic submucosal dis-
section (ESD), laparoscopic gastrectomy, or open gas-
trectomy. In addition, preoperative prediction regarding* Correspondence: chpark@catholic.ac.kr
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reproduction in any medium, provided the orthe presence of lymph-node metastasis is a decisive fac-
tor in selecting endoscopic or surgical resection.
The development of endoscopic ultrasonography (EUS)
has increased the accuracy of preoperative staging and diag-
nosis of upper gastrointestinal malignancies, including gas-
tric cancer, and has had a major effect in determining the
therapeutic options for gastric cancer. At present, EUS is
the most valuable method for T staging of gastric cancer
and is also used for detecting regional lymph-node involve-
ment [3-6]; however, the accuracy of EUS for T and perigas-
tric N staging varies [6,7]. In addition, there have been few
studies assessing the accuracy rate of T staging with regard
tothe gastric wall layers (mucosa, submucosa, muscular
propria, sub-serosa, and serosa), which can be identified by
EUS. Consequently, there are no guidelines regarding the
clinicopathological factors requiring attention during a EUS
check-up, and the accuracy rates are still undetermined.
The aim of this study was to determine the accuracy of
EUS with regard to tumor depth and nodal metastasis,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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accuracy of EUS in gastric cancer, with a particular focus
on the detailed gastric wall layers.
Methods
Ethics approval
The study protocol was approved by the institutional
review board (KC10RISE0441).
Patients
From January to December 2009, 491 patients under-
went gastric cancer surgery at Seoul St. Mary’s Hospital,
Seoul, Korea.We prospectively collected the clinico-
pathological date of 436 patients who were diagnosed
with pathological cancer staging (the remaining patients
comprised thirty-seven patients who could not undergo
gastric resection, sixteen patients for whom preoperative
cancer staging was difficult (including incomplete ESD,
neoadjuvant chemotherapy, and remnant gastric cancer)
and two patients with pathological non-measurableFigure 1 Endoscopic ultrasonography (EUS) (A) EUS showing normal
clearly visible (arrow). (B) EUS of early gastric cancer (T1a), showing a foc
image of advanced gastric cancer (T3); the tumor involves all layers and ex
EUS showing a metastatic lymph node (dotted line).lesions). Of these 436 patients, 309 (184 men (59.5%),
125 women (40.5%); mean ± SD age 57.5 ± 12.2 years,
range 26–86 years),for whom EUS was used as a pre-
operative diagnostic tool, were enrolled in this retro-
spective study.
Endoscopic ultrasonography equipment and technique
EUS was performed with a radial transducer (12 to
20 MHz; GF-UM2000; Olympus, Tokyo, Japan), and in
some cases, a 20 MHz miniprobe (Olympus) was also
used. After the stomach was filled with 300 to 600 mL of
water, the tumor infiltration depth was evaluated based
on the five-layered gastric wall structure. Assessment of
tumor depth by EUS was made in accordance with the
International Union Against Cancer TNM Classification
(6th edition): T1a, cancer invading the mucosal layer;
T1b, cancer invading the submucosal layer; T2a, cancer
invading the muscularis propria; T2b, cancer invading the
subserosal layer; T3, cancer penetrating the serosal layer;
and T4, cancer invading adjacent structures (Figure 1).layers of gastric wall, with the five-layered echo pattern being
al thickening area confined to layers 1 and 2(dotted line). (C) EUS
tends beyond the the outermost layer of the gastric wall (arrow). (D)
Table 1 Patient demographics and pathological stages
Variable Result (n = 309)


























AJCC, American Joint Committee on Cancer.
1Values are means ± standard deviation (range). All other values are n (%).
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identified hypoechoic structures in perigastric tissues.
Hypoechoic nodes larger than 5 mm with round and
well-demarcated margins were considered positive for
metastasis. A diagnosis of N2 stage was made when the
lymph-node metastasis was > 30 mm from the primary
lesion. Fine-needle aspiration (FNA) was not performed
for lymph nodes that appeared to be metastatic.
Assessment of endoscopic ultrasonography staging
The preoperative EUS T and N staging results were com-
pared with each pathological stage. The accuracy, over-
staging, and understaging rates for EUS T staging were
calculated using two methods: all stages (T1, T2, T3,
and T4) and all detailed stages (T1a, T1b, T2a, T2b, T3,
and T4).The correlations between EUS T overstaging
and understaging and histopathological factors (including
tumor size, tumor location, histological type, ulceration,
and Lauren’s classification,) were analyzed for the 309
cases. Tumor size was classified as less than 20 mm, 2 to
50 mm, or greater than 50 mm. Tumor locations were
subclassified using two criteria. One group was divided
into upper, middle, and lower thirds, based on the longitu-
dinal portions of the stomach, and the other group was
divided into wall, curvature, and circumferential, sorted
according to the cross-sectional portions. The histological
types of gastric cancer, in accordance with the World
Health Organization classification, were categorized into
differentiated and undifferentiated types. Poorly differen-
tiated tubular adenocarcinoma, signet ring cell adenocar-
cinoma, and mucinous adenocarcinoma belonged to the
undifferentiated group. The accuracy rate for EUS N sta-
ging And the correlations between EUS N accuracy and
histopathological factors that added to tumor depth were
analyzed for the 309 cases.
Statistical analysis
Tumor characteristics and their EUS stages were ana-
lyzed using the χ2 test or Fisher’s exact test for propor-
tions. Factors with an effect on EUS TN staging were
analyzed by binary multiple regression analysis. Statistical
analyses were performed with SPSS software (version




Of the 309 patients, the pathological T staging showed
that there were 107 cases of T1a (40.8%), 85 T1b
(32.4%), 36 T2a (13.7%), 34 T2b (13.0%), 45 T3 (14.6%),
and 2 of T4 (0.6%). For pathological N stage, there were
213 N0 cases, which comprised the largest proportion
(68.9%). The clinical data and pathological stage of each
group are shown in Table 1.T staging by endoscopic ultrasonography
In all 309 cases examined by EUS, the overall accuracy
of EUS for T staging was 70.2% (217/309). The rates of
overstaging and understaging were 23.6% (73/309) and
6.1% (19/309), respectively. In the detailed T staging of
309 cases, the overall accuracy rate decreased to 43.0%
(133/309), and the overstaging and understaging rates
increased to 44.3% (137/309) and 12.6% (39/309), re-
spectively. Two versions of the comparison of T stage by
EUS and pathology are shown in Table 2.
T overstaging was correlated with tumor size (P = 0.03
however, T understaging was not related to any clinico-
pathological factor. In multivariate analysis, a tumor size
greater than 50 mm was a significant factor correlated
with overstaging by EUS (odds ratio (OR) = 2.09; 95%
confidence interval (CI) 1.13 to 3.88, P < 0.02) (Table 3;
Table 4). Subgroup analysis was performed, and the
cases were divided into two groups based on tumor
depth for overstaging and understaging: early gastric
cancers (EGCs; T1a, T1b) and advanced gastric cancers
(AGCs; T2a, T2b, T3, T4). Tumor size was correlated
Table 2 Accuracy of endoscopic ultrasonography (EUS) for T staging
EUS stage Pathological stage EUS stage Pathological stage
T1 T2 T3 T4 Total T1a T1b T2a T2b T3 T4 Total
T1 155 9 3 0 174 T1a 34 11 0 0 0 0 46
T2 36 37 5 0 87 T1b 60 50 6 3 3 0 128
T3 1 22 25 2 45 T2a 11 21 16 9 2 0 64
T4 0 2 12 0 3 T2b 2 2 4 8 3 0 23
T3 0 1 9 13 25 2 45
T4 0 0 1 1 12 0 3
Total 192 70 45 2 309 Total 107 85 36 34 45 2 309
Overall accuracy, % 70.2 43.0
Overall accuracy, % 1 – 41.2
1pT1a–pT2b; n = 262.
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0.001, respectively), and cross-sectional tumor location
(P = 0.04) was associated with overstaging in the AGC
group. In multivariate analysis for subgroup, a tumor
size greater than 50 mm was also a factor affecting
EUS overstaging in the EGC (OR = 3.00, 95% CI, 1.19
to 7.56; P = 0.02) and AGC (OR = 5.40; 95% CI, 2.26Table 3 Histopathological factors affecting endoscopic






Total 309 137 (44.3) 39 (12.6)
Tumor size, mm
<20 80 30 (37.5) 0.03 7 (8.8) 0.42
2–50 141 58 (41.1) 21 (14.9)
≥50 88 49 (55.7) 11 (12.5)
Tumor locationI
Upper 18 6 (33.3) 0.62 3 (16.7) 0.28
Middle 137 61 (44.5) 21 (15.3)
Lower 154 70 (45.5) 15 (9.7)
Tumor locationII
Wall 162 70 (43.2) 0.32 20 (12.3) 0.65
Curvature 131 57 (43.5) 16 (12.2)
Circumferential 16 10 (62.5) 3 (18.8)
Histological type
Differentiated 147 66 (44.9) 0.85 21 (14.3) 0.40
Undifferentiated 162 71 (43.8) 18 (11.1)
Ulceration
Yes 227 94 (41.4) 0.08 31 (13.7) 0.36
No 82 43 (52.4) 8 (9.8)
Lauren
Intestinal type 142 63 (44.4) 0.88 16 (11.3) 0.15
Mixed type 60 25 (41.7) 12 (20.0)
Diffuse type 107 49 (45.8) 11 (10.3)to 12.91; P < 0.01) subgroups (Table 4; Table 5). No fac-
tors were significantly associated with understaging in
subgroup analysis (data not shown).N staging by endoscopic ultrasonography
The comparative results of N staging by EUS and the
pathological reports are shown in Table 6. The N staging
accuracy in the 309 patients was 71.2%. Incorrect nodal sta-
ging by EUS was correlated with tumor size (P < 0.001),
cross-sectional tumor location (P < 0.001), and tumor
depth (P < 0.001), and these three factors were significantly
associated with inaccurate nodal staging on multivariate
analysis. Tumor size greater than 50 mm was the strongest
factor for inaccurate EUS nodal staging (OR = 8.170, 95%
CI 2.47 to 27.05, P = 0.001), and a tumor size greater than
20 mm was also a significant factor (OR = 4.389, 95% CI
1.45 to 13.31, P < 0.010). Circumferential location was
identified as a significant factor (OR = 4.38, 95% CI 1.02 to
18.83, P < 0.05), and all tumor depths over the mucosal
layer were significant factors for inaccurate nodal staging
(submucosa, OR = 3.324, 95% CI 1.35 to 8.20, P < 0.01,
muscular propria, OR = 6.92, 95% CI 2.52 to 19.03, P <
0.001, sub-serosa, OR = 4.52, 95% CI 1.57to12.10, P < 0.01,
serosa-exposed, OR = 6.50, 95% CI 2.28to 18.51, P < 0.001)
(Table 7).Table 4 Multivariate analysis of histopathological factors
affecting EUS T staging
Variable P Odds Ratio 95% CI
Overstaging
Tumor size ≥ 50 mm 0.020 2.09 1.13 to 3.88
EGC overstaging
Tumor size ≥ 50 mm 0.02 3.00 1.19 to 7.56
AGC overstaging
Tumor size ≥ 50 mm < 0.001 5.40 2.26 to 12.91
AGC, advanced gastric cancer; CI, confidence interval; EGC, early gastric cancer;
EUS, endoscopic ultrasonography.
Table 6 Accuracy of endoscopic ultrasonography (EUS)
for N staging
EUS stage Pathological stage
N0 N1 N2 N3 Total
N0 190 44 1 1 236
N1 22 27 7 10 66
N2 1 1 3 2 7
Total 213 72 11 13 309
Overall accuracy, % 71.2
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The accuracy of EUS for gastric cancer varies. In previ-
ous studies, EUS has had an accuracy of 65% to 92% for
T staging, and 50% to 90% for N staging [6-13]. In most
studies, T stage has been classified as T1, T2, T3, or T4,
instead of T1a, T1b, T2a, T2b, T3, and T4 [3-5,9-27]. A
few studies have estimated the accuracy of detailed T sta-
ging by EUS, but they were limited to distinguishing the
mucosa from the submucosal layer [8,28-30]. In the
present study, we found the overall accuracy of EUS for
T staging was 70.2%, which was similar to previous stud-
ies. However, when T stage was subdivided into the
detailed stages, the overall accuracy rate for T staging
was only 43.0%, and the overstaging rate increased
sharply to 44.3%. These unexpected results were mainly
the result of overstaging of mucosal lesions into sub-
mucosal lesions, and occurred in 60 cases.
EUS images of the normal gastric wall show a five-
layered structure. Gastric cancer invading the serosa can
be adequately diagnosed by traditional endoscopy and
computed tomography (CT). EUS tends to overestimate
the T stage because of the difficulty in distinguishingTable 5 Histopathological factors affecting T overstaging in t
Variables EGCs
n Overstaging, n (%)
Total 192 97 (50.5)
Tumor size, mm
< 20 75 30 (40.0)
2to50 90 49 (54.4)
≥ 50 27 18 (66.7)
Tumor locationI
Upper 3 1 (33.3)
Middle 81 42 (51.9)
Lower 108 54 (50.0)
Tumor locationII
Wall 115 57 (49.6)
Curvature 75 39 (52.0)
Circumferential 2 1 (50.0)
Histological type
Differentiated 102 47 (46.1)
Undifferentiated 90 50 (55.6)
Ulceration
Yes 139 68 (48.9)
No 53 29 (54.7)
Lauren
Intestinal type 101 46 (45.5)
Mixed type 31 18 (58.1)
Diffuse type 60 33 (55.0)
EGCs, early gastric cancers; AGCs, advanced gastric cancers.
10to50 mm.invasion through the subserosal fat (T2b) and the serosa
(T3), which is very thin in some areas [22]. EUS findings
for gastric cancer at less than stage T2 can profoundly
affect selection of operative method, unlike stages more
severe than T3, for which the treatment plan involves
open gastrectomy. The treatment algorithm based on
the detailed T stage by EUS is described in Figure 2. In
our population of 262 cases limited to T2b, the overall
accuracy rate decreased to 41.2%, and the overstaging
rate increased to 47.7%. Therefore, we attempted to
identify the factor(s) affecting the overstaging of depth,he subgroups
AGCs
P n Overstaging, n (%) P
117 40 (34.2)
0.03
56 9 (16.1)1 < 0.001
61 31 (50.8)
0.87 15 5 (33.3)
56 19 (33.9) 0.99
46 16 (34.8)
0.88 47 13 (27.7)
56 18 (32.1)
14 9 (64.3) 0.04
0.19 45 19 (42.2) 0.15
72 21 (29.2)
0.47 88 26 (29.5) 0.07
29 14 (48.3)
0.33 41 17 (41.5) 0.32
29 7 (24.1)
47 16 (34.0)
Table 7 Histopathological factors affecting endoscopic ultrasonography (EUS) N staging
Variables n Incorrect staging, n (%) P Odds ratio (95% CI) P
Total 309 90 (29.1)
Tumor size, mm
< 20 mm 80 4 (5.0) < 0.001 4.389 (1.447to13.307) < 0.01
2 to 50 mm 141 38 (27.0) 8.170 (2.468to27.050) 0.001
≥ 50 mm 88 48 (54.5)
Tumor location I
Upper 18 9 (50.0) 0.13
Middle 137 38 (27.7)
Lower 154 43 (27.9)
Tumor location II
Wall 162 38 (23.5) < 0.001 1.00 (0.55to1.82) 0.10
Curvature 131 39 (29.8) 4.38 (1.02to18.83) 0.05
Circumferential 16 13 (81.3)
Histological type
Differentiated 147 41 (27.9) 0.65
Undifferentiated 162 49 (30.2)
Ulceration
Yes 227 63 (27.8) 0.38
No 82 27 (32.9)
Lauren
Intestinal type 142 38 (26.8) 0.23
Mixed type 60 23 (38.3)
Diffuse type 107 29 (27.1)
Tumor depth
Mucosa 107 8 (7.5) 3.32 (1.35to8.20) < 0.01
Sub-mucosa 85 22 (25.9) 6.92 (2.52to19.03) < 0.001
Muscular propria 36 16 (44.4) 4.52 (1.57to12.10) < 0.01
Sub-serosa 34 15 (44.1) 6.49 (2.28to18.51) < 0.001
Serosa-exposed 47 29 (61.7) < 0.001
CI, confidence interval.
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EGCs and AGCs.
Our results showed that the rate of overstaging
tended to increase with increasing tumor size, and a
tumor size greater than 50 mm was a significant factor
affecting EUS overstaging. However, the proportion of
EGCs (97/137; 70.8%) was greater than that of AGCs
(40/137; 29.2%) in cases with overstaging. We per-
formed subgroup analysis to determine whether tumor
size, identified as an influencing factor for T oversta-
ging, would work in the same way in both groups with
very different proportions. Large tumor size was asso-
ciated with T overstaging in univariate analysis of both
groups, and a tumor size greater than 50 mm was sig-
nificantly associated. Kim et al. [31] reported that
tumors larger than 30 mm could cause EUS overstaging.
In their study, in which the T1 stage was subdivided
into T1a and T1b, but T2 stage was not subdivided, theoverall T staging accuracy rate was 71.8%. Of our 309
cases, 171 (55.3%) had tumors larger than 30 mm, with
39% (75/192) were larger than 30 mm in the EGC
group. As our results showed a correlation between
tumor size and T overstaging, we considered that many
tumors greater than 30 mm in size resulted in the low
accuracy rate.
Compared with the overall accuracy rate for N staging
which was 71.2%, the accuracy rate of the 262 cases with
tumor location below the sub-serosa was 76.7%. In con-
trast to T staging accuracy, the accuracy of N staging
increased when we excluded AGCs more severe than
T3. This result suggested that tumor depth might influ-
ence perigastric nodal detection by EUS, and tumor
depth was added as a histopathological factor possibly
associated with N staging accuracy. Our results showed
that as tumor invasion became deeper, incorrect nodal
detection increased as expected, and large-sized tumors
Figure 2 Treatment algorithm for gastric cancer based on the detailed tumor (T) stages. EUS, endoscopic ultrasonography; UL, ulceration.
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The proportion of incorrect nodal staging increased
equally to 44% in both the muscular propria and sub-
serosal layers, and these layers (AGC) had higher ORs
than the submucosal layer (EGC). T overstaging was cor-
related with a tumor size greater than 50 mm, whereas
incorrect N staging was significantly associated with
tumors greater than 20 mm. ESD is currently performed
for differentiated, intramucosal lesions of less than
20 mm in diameter without ulcerations, because a tumor
size greater than 30 mm, ulcer formation, and lymphatic/
vascular involvement are regarded as independent risk
factors for lymph-node metastasis in intramucosal can-
cer [32,33]. However, the expanded ESD criteria in-
clude lesions greater than 20 mm in diameter, ulcerative
lesions, and minute submucosal cancer. Judging from
our results, careful examination of nodal metastases in
preoperative EUS staging and cooperative staging with
another method, such as CT, is essential for determining
the treatment plan for EGC lesions greater than 20 mm
in diameter.
Although there was no statistical significance in
multivariate analysis, circumferential tumor location
was associated with T overstaging of AGCs in sub-
group analysis (P = 0.04). In addition, this location
was a significant factor determining incorrect nodal
staging of EUS (P = 0.05). A tumor must have a broad
surface to occupy a circumferential location within the
stomach; therefore, the borderline significance of thisparticular location was considered as a secondary ef-
fect caused by the large size of the tumor.
There are some limitations to our study. First, the
examiners who performed the EUS all belong to a single
institution. Although many cases were enrolled in our
study, the results may be just a reflection of the prefer-
ence of a single institution. However, all examiners are
endoscopic specialists of the upper gastrointestinal tract,
and perform more than 100 cases of EUS every year.
The second limitation is the definition of EUS N staging.
EUS N staging of this study includes the concept of dis-
tance and is similar to the nodal staging of Japanese
Gastric Cancer Association which is based on the loca-
tion of metastatic lymph nodes. Because the N staging
International Union Against Cancer TNM Classification
(6th edition), which was used for pathologic nodal sta-
ging in this study, is based on the number of metastatic
lymph nodes, the comparison of EUS N staging with
pathologic N staging might be inappropriate. Addition-
ally, there is no criterion for N3 staging using EUS.
However, based on our results, we suggest that extra
attention should be paid not only to preoperative EUS
T staging but to N staging for large-sized EGCs. In
addition, because tumors larger than 50 mm, in which
the possibility of T overstaging is high, are mostly
affiliated with AGCs, and the accuracy of nodal staging
tends to decrease with increasing tumor depth, the effi-
cacy of routine preoperative EUS for AGCs should be
evaluated. Reddy et al. [34] reported that more than half
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efficacy of EUS for managing patients with gastric cancer.
They also reported a trend toward underutilization of
EUS when staging gastric cancer, which was unaffected
by the availability of EUS in practice. At present, there
are no guidelines for indicating EUS examination. EUS
guidelines must be established to increase the accuracy
of EUS and expand its use.
Conclusions
The accuracy of T staging by EUS appeared to decrease
with detailed T staging. T overstaging, which caused
decreased accuracy, was correlated with lesions greater
than 50 mm, and incorrect EUS nodal staging was asso-
ciated with larger tumor size and deeper tumor infiltration.
Consequently, careful EUS examination in association with
other diagnostic tools must precede treatment planning for
gastric cancer with these characteristics. Improvement in
EUS equipment and techniques will be essential to over-
come the weak points of the method, and an implementa-
tion guideline should be developed for improvement of the
clinical efficacy of EUS.
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